All Posts: lung cancer
-
Georgetown-Led Study Leads to First FDA-Approved Drug in Decades to Improve Survival in Small Cell Lung Cancer
The U.S. Food and Drug Administration’s approval of a drug used in combination with chemotherapy for the initial treatment of extensive-stage small cell lung cancer marks the end of numerous failed attempts to improve survival for those with the deadly disease.
Category: Lombardi Stories